Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download 2014 stem cell symposium - Translational Research Institute
Document related concepts
Transcript
2014 STEM CELL SYMPOSIUM WEDNESDAY, 10 – THURSDAY, 11 SEPTEMBER 2014 TRANSLATIONAL RESEARCH INSTITUTE, BRISBANE FREE REGISTRATION A host of international and national speakers will address the cellular and molecular biology of mesenchymal stem cells, mesenchymal stromal cells, bioengineering applications for stem cell therapies and the results of clinical trials using stem cells and their progenitors. Abstracts on any aspects of stem or progenitor cells are welcome. There will be prizes for the three best abstracts submitted by students and for the three best abstracts submitted by postdoctoral fellows. Abstracts can be submitted to [email protected] and are due 1 August 2014. To register your attendance visit our event registration site. Places are limited. INTERNATIONAL SPEAKERS Professor Frank Barry, National University of Ireland The host response to allogeneic mesenchymal stromal cells (MSCs) Professor Barry is a principle investigator at the Regenerative Medicine Institute. He directs a large group of researchers who focus on the development of new repair strategies in stem cell therapy and gene therapy in orthopaedics. Professor Katarina Le Blanc, Karolinska Institute and Huddinge Hospital, Sweden The impact of MSCs on the innate and adaptive immune systems and The role of MSCs in the management of graft-versus-host disease and other serious diseases Professor Le Blanc pioneered the use of mesenchymal stromal cells to treat graft-versus-host disease, which is a common and sometimes fatal complication of bone marrow transplants. She has also investigated the immunological properties of these cells in an attempt to determine their method of action. NATIONAL SPEAKERS Dr Dimitrios Cakouros, University of Adelaide Epigenetics of MSCs Dr Daniel Chambers, The Prince Charles Hospital Cell therapy for pulmonary diseases Dr Mike Doran, Queensland University of Technology The role of bioengineering in the application of MSCs for therapeutic purposes Dr Jessica Frith, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland Topic: Mesenchymal stem cells therapies and hydrogel delivery systems Associate Professor Caroline Gargett, Monash University Endometrial MSCs for uterine prolapse Associate Professor Damien Harkin, Queensland University of Technology The role of MSCs in corneal disease Professor Geoff Hill, QIMR Berghofer Medical Research Institute Topic: Graft versus host disease and the cytokine storm Dr James Hudson, The University of Queensland Topic: Stem cells and cardiac muscle model systems Professor Dietmar Hutmacher, Queensland University of Technology Applying bone tissue engineering in combination with haempoetic stem cells for humanizing mice Dr Nina Ilic, Mater Health Services cGMP manufacturing of placenta-derived MSCs for clinical trials Associate Professor Kiarash Khoshterani, The University of Queensland Centre for Clinical Research and the Translational Research Institute Cellular and molecular biology of skin stem cells and endothelial cells Professor Melissa Little, Institute of Molecular Bioscience, The University of Queensland Endogenous kidney mesenchymal stem cells show compartment-specific epithelial potential Dr Rebecca Pelekanos, The University of Queensland Centre for Clinical Research The differences in MSCs from different organs and Making iPS cells from MSCs Professor Ed Stanley, Murdoch Children’s Research Institute and The Royal Children’s Hospital Pluripotent stem cells and diabetes mellitus Professor Yin Xiao, Queensland University of Technology MSC identify and recruitment during osteogenesis Dr Deanne Whitworth, School of Veterinary Medicine, The University of Queensland A pre-clinical canine model for joint repair with iPSc derived MSCs Associate Professor Ernst Wolvetang, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland Novel insights into cerebellar degeneration using A-T iPSC derived cerebellar cells Dr Mark Young, Mater Private Hospital and Mater Research The role of MSCs in the management of musculo-skeletal disorders
